Methotrexate reduces TNF-alpha and beta adrenergic receptor expression and improves left ventricle function in induced Takotsubo myocardiopathy in rats.
Methotrexate carried in lipid nanoparticles pronouncedly improves the functional and inflammatory status of the heart following acute myocardium infarction induced in rats.